Four‐fold Channel‐Nicked Human Ferritin Nanocages for Active Drug Loading and pH‐Responsive Drug Release
Human ferritins are emerging platforms for non‐toxic protein‐based drug delivery, owing to their intrinsic or acquirable targeting abilities to cancer cells and hollow cage structures for drug loading. However, reliable strategies for high‐level drug encapsulation within ferritin cavities and prompt...
Saved in:
Published in | Angewandte Chemie International Edition Vol. 57; no. 11; pp. 2909 - 2913 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Germany
Wiley Subscription Services, Inc
05.03.2018
|
Edition | International ed. in English |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Human ferritins are emerging platforms for non‐toxic protein‐based drug delivery, owing to their intrinsic or acquirable targeting abilities to cancer cells and hollow cage structures for drug loading. However, reliable strategies for high‐level drug encapsulation within ferritin cavities and prompt cellular drug release are still lacking. Ferritin nanocages were developed with partially opened hydrophobic channels, which provide stable routes for spontaneous and highly accumulated loading of FeII‐conjugated drugs as well as pH‐responsive rapid drug release at endoplasmic pH. Multiple cancer‐related compounds, such as doxorubicin, curcumin, and quercetin, were actively and heavily loaded onto the prepared nicked ferritin. Drugs on these minimally modified ferritins were effectively delivered inside cancer cells with high toxicity.
Spontaneous and high‐level uptake of diverse drugs onto a ferritin nanocage was achieved by fractionally opening hydrophobic channels of ferritin. Drug–FeII complexes were actively and stably accumulated in this nicked ferritin and delivered inside cells by the cell targeting ability of ferritin in a pH‐responsive manner. |
---|---|
Bibliography: | These authors contributed equally to this work. |
ISSN: | 1433-7851 1521-3773 |
DOI: | 10.1002/anie.201800516 |